Author

J. Canilho

Institution: Exigo Consultores (Portugal)

Observed institutions: University of Lisbon, National Institute of Health Dr. Ricardo Jorge, Exigo Consultores (Portugal)

OpenAlex ID: A5052166178

PBI46 Cost-Effectiveness of Treatment Sequences Initiating with Risankizumab for the Treatment of Moderate to Severe Psoriasis in Portugal

2020 · C. Carvalho, M. Batista, et al. · Value in Health · 1

Cardiovascular risk factors in a young adult population

2014 · J. Canilho, A.C. Alves, et al. · Atherosclerosis

Works count: 2

Citation count: 1

H-index: 1

I10-index: